We thank the National Health and Medical Research Council (Development Grants 303415 and 404528), the Uni. of Wollongong, and Avexa Ltd for financial support; R. Nation (Monash University) for assistance with some testing against Gram-negative pathogens; and Washington Biosciences, Inc, Maryland (USA) for the nasal decolonisation and systemic studies.
Binaphthyl-Based Dicationic Peptoids with Therapeutic Potential†
Article first published online: 11 DEC 2009
Copyright © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Volume 122, Issue 3, pages 547–550, January 12, 2010
How to Cite
Bremner, John B., Keller, Paul A., Pyne, Stephen G., Boyle, Timothy P., Brkic, Z., David, Dorothy M., Garas, A., Morgan, J., Robertson, M., Somphol, K., Miller, Michael H., Howe, Adam S., Ambrose, P., Bhavnani, S., Fritsche, Thomas R., Biedenbach, Douglas J., Jones, Ronald N., Buckheit, Robert W., Watson, Karen M., Baylis, D., Coates, Jonathan A., Deadman, J., Jeevarajah, D., McCracken, A. and Rhodes, David I. (2010), Binaphthyl-Based Dicationic Peptoids with Therapeutic Potential. Angew. Chem., 122: 547–550. doi: 10.1002/ange.200904392
- Issue published online: 7 JAN 2010
- Article first published online: 11 DEC 2009
- Manuscript Revised: 7 SEP 2009
- Manuscript Received: 6 AUG 2009
- National Health and Medical Research Council. Grant Numbers: 303415, 404528
- Uni. of Wollongong
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley-Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.